Xiaoli Lan, PhD
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
16
2
2
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+8 more interventions
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (16)
Showing 10 of 16 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Zhenfeng Zhang, MD, PhD
Second Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
Shared therapeutic areas:
lin shen
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (16)
Showing 16 of 16 trials
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma
68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients
Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma
Visualized Monitoring of Fibrosis Formation in Heart Failure With 68GA-FAPI PET
18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC
Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma
Clinical Application of Fibroblast Activation Protein PET/MRI in Liver Fibrosis
Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
The Value of PET Quantitative Analysis of Coronary Physiology in Coronary Microvascular Disease
All 16 trials loaded